- Home
- OABI vs HFRO Comparison
OABI vs HFRO Comparison
Compare OABI & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- HFRO
- Stock Information
- Founded
- OABI 2012
- HFRO 2000
- Country
- OABI United States
- HFRO United States
- Employees
- OABI N/A
- HFRO N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- HFRO Finance/Investors Services
- Sector
- OABI Health Care
- HFRO Finance
- Exchange
- OABI Nasdaq
- HFRO Nasdaq
- Market Cap
- OABI 459.1M
- HFRO 402.7M
- IPO Year
- OABI N/A
- HFRO N/A
- Fundamental
- Price
- OABI $3.85
- HFRO $5.25
- Analyst Decision
- OABI Strong Buy
- HFRO
- Analyst Count
- OABI 4
- HFRO 0
- Target Price
- OABI $9.00
- HFRO N/A
- AVG Volume (30 Days)
- OABI 509.5K
- HFRO 421.7K
- Earning Date
- OABI 11-12-2024
- HFRO 01-01-0001
- Dividend Yield
- OABI N/A
- HFRO 12.00%
- EPS Growth
- OABI N/A
- HFRO N/A
- EPS
- OABI N/A
- HFRO 1.23
- Revenue
- OABI $20,409,000.00
- HFRO $44,535,929.00
- Revenue This Year
- OABI N/A
- HFRO N/A
- Revenue Next Year
- OABI $71.78
- HFRO N/A
- P/E Ratio
- OABI N/A
- HFRO $5.50
- Revenue Growth
- OABI N/A
- HFRO N/A
- 52 Week Low
- OABI $3.56
- HFRO $5.92
- 52 Week High
- OABI $6.72
- HFRO $9.38
- Technical
- Relative Strength Index (RSI)
- OABI 40.94
- HFRO 25.87
- Support Level
- OABI $3.62
- HFRO $5.34
- Resistance Level
- OABI $4.19
- HFRO $5.54
- Average True Range (ATR)
- OABI 0.23
- HFRO 0.13
- MACD
- OABI -0.06
- HFRO -0.02
- Stochastic Oscillator
- OABI 18.40
- HFRO 15.79
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. The company's portfolio of investments includes different industry investments such as Financial, Communication Services, Energy, Healthcare, Materials, and others.